Meds Safety

Aug- 2023 -

8 August

Opioid Medications Reach Just 20% of U.S. Opioid Strugglers – Study

The persistent and troubling U.S. opioid abuse epidemic remains a critical issue, as overdose deaths continue to soar. Despite the…

7 August

Dr. Oche Otorkpa PG Cert, MPH, PhD

Controversial Dupixent Commercial Driving Sales OF New Eczema Drug

Jolie, the youthful dancer showcased in the Dupixent commercial, achieved recognition following her appearance. However, despite the ensuing controversy surrounding…

5 August

Dr. Oche Otorkpa PG Cert, MPH, PhD

FDA Approves Sage Therapeutics Zurzuvae For Postpartum Depression (PPD)

On August 04, 2023, the U.S. Food and Drug Administration (FDA) reached a groundbreaking decision by granting its approval for…

4 August

Dr. Oche Otorkpa PG Cert, MPH, PhD

Galapagos Withdraws Jyseleca Applications in Europe and Revises Sales Projections

Galapagos, a Belgium biotech company, has experienced setbacks with its drug Jyseleca (filgotinib). Based on the results of a phase…

4 August

Dr. Oche Otorkpa PG Cert, MPH, PhD

ReVive: The Second OTC Naloxone Spray Approved by FDA

The U.S. Food and Drug Administration (FDA) has taken a significant step forward in addressing the opioid crisis by approving…

3 August

Dr. Oche Otorkpa PG Cert, MPH, PhD

Gastroparesis Life Expectancy

Gastroparesis is a medical condition that affects the normal movement and emptying of the stomach. The term “gastroparesis” comes from…

3 August

Dr. Oche Otorkpa PG Cert, MPH, PhD

Lawsuit Alleges Ozempic and Mounjaro Manufacturers Concealed Stomach Paralysis Risks

Jaclyn Bjorklund, a Louisiana woman has filed a lawsuit against Novo Nordisk and Eli Lilly. She claims that the drug…

3 August

Dr. Oche Otorkpa PG Cert, MPH, PhD

Central Admixture Pharmacy Services (CAPS) Recalls 13,792 Bags Of Cardioplegia

Central Admixture Pharmacy Services (CAPS) a nationwide compounding pharmacy business that specializes in providing custom-made medications for hospitals and outpatient…

3 August